Citadel Advisors
OPRX icon

Citadel Advisors’s OptimizeRx OPRX Stock Holding History

Citadel Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,500
Closed -$441K – 13685
2025
Q3 		$441K Sell
21,500
-54,900
-72% -$871K ﹤0.01% 9439
2025
Q2 		$1.03M Sell
76,400
-17,500
-19% -$191K ﹤0.01% 7016
2025
Q1 		$813K Buy
93,900
+70,500
+301% +$431K ﹤0.01% 7405
2024
Q4 		$114K Buy
23,400
+5,300
+29% +$29.6K ﹤0.01% 11276
2024
Q3 		$140K Sell
18,100
-13,200
-42% -$117K ﹤0.01% 10658
2024
Q2 		$313K Buy
31,300
+30,200
+2,745% +$332K ﹤0.01% 9050
2024
Q1 		$13.4K Sell
1,100
-19,300
-95% -$280K ﹤0.01% 13301
2023
Q4 		$292K Buy
20,400
+1,700
+9% +$16.3K ﹤0.01% 9213
2023
Q3 		$145K Buy
18,700
+4,000
+27% +$43.5K ﹤0.01% 10408
2023
Q2 		$210K Sell
14,700
-8,900
-38% -$127K ﹤0.01% 9774
2023
Q1 		$345K Buy
23,600
+10,900
+86% +$182K ﹤0.01% 9083
2022
Q4 		$213K Buy
12,700
+1,300
+11% +$22.5K ﹤0.01% 10005
2022
Q3 		$169K Sell
11,400
-3,400
-23% -$67.2K ﹤0.01% 10584
2022
Q2 		$405K Sell
14,800
-24,300
-62% -$720K ﹤0.01% 9120
2022
Q1 		$1.47M Buy
39,100
+9,500
+32% +$420K ﹤0.01% 6767
2021
Q4 		$1.84M Sell
29,600
-2,500
-8% -$189K ﹤0.01% 6447
2021
Q3 		$2.75M Sell
32,100
-10,000
-24% -$627K ﹤0.01% 5573
2021
Q2 		$2.61M Sell
42,100
-6,600
-14% -$336K ﹤0.01% 5932
2021
Q1 		$2.37M Buy
48,700
+29,700
+156% +$1.43M ﹤0.01% 5999
2020
Q4 		$592K Buy
+19,000
New +$465K ﹤0.01% 7834

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's OPRX Position: Q1 2026 in Review

Citadel Advisors sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 11,976 shares — an estimated $111K sold.

Citadel Advisors first reported a position in OPRX in Q4 2020 and held it in 19 quarters. The position peaked at $2.76M in Q1 2023. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Citadel Advisors reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 11,976 OptimizeRx shares in Q1 2026, an estimated $111K.
  • Citadel Advisors first reported a position in OptimizeRx in Q4 2020 and held it in 19 quarters.
  • Citadel Advisors's OptimizeRx position peaked at $2.76M in Q1 2023.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.